Back
Royal Caribbean Group Vs. 4D Molecular Therapeutics Industry Stock Comparison
Buy
69
RCL
Royal Caribbean Group
Last Price:
141.02
Seasonality Move:
1.78%
Sell
48
FDMT
4D Molecular Therapeutics
Last Price:
25.68
Seasonality Move:
-0.46%
Buy
69
Royal Caribbean Group (RCL)
is a Buy
Is Royal Caribbean Group a Buy, Sell or Hold?
- The current Royal Caribbean Group [RCL] share price is $141.04. The Score for RCL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- RCL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $25.70. The Score for FDMT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCL Stock Price Chart
What is Royal Caribbean Group's stock price today?
-
The Royal Caribbean Group share price today is $141.04
The current trend is moderately bullish and RCL is experiencing selling pressure, which indicates risk of future bearish movement.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $25.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight buying pressure.
RCL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.54 | Buy |
Relative Strength Index (14 RSI): | 58.97 | Buy |
Chaikin Money Flow: | -598987 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (130.18 - 141.12) | Buy |
Bollinger Bands (100): | (120.94 - 135.78) | Buy |
FDMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.46 | Sell |
Relative Strength Index (14 RSI): | 46.44 | Sell |
Chaikin Money Flow: | 181025 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.49 - 27.11) | Sell |
Bollinger Bands (100): | (20.4 - 30.12) | Buy |
RCL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 140.3 | Buy |
20-day SMA: | 136.37 | Buy |
50-day SMA: | 133.95 | Buy |
200-day SMA: | 113.55 | Buy |
8-day EMA: | 140.53 | Buy |
20-day EMA: | 138.06 | Buy |
50-day EMA: | 133.7 | Buy |
200-day EMA: | 115.37 | Buy |
FDMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.16 | Sell |
20-day SMA: | 25.4 | Buy |
50-day SMA: | 28.12 | Sell |
200-day SMA: | 19.56 | Buy |
8-day EMA: | 25.86 | Sell |
20-day EMA: | 26.05 | Sell |
50-day EMA: | 26.44 | Sell |
200-day EMA: | 21.92 | Buy |
Royal Caribbean Group Earnings Growth & RCL Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $1.53 per share, an increase this year of $4.34 per share, and an increase next year of $1.66 per share.
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.24 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.24 per share.
Royal Caribbean Group Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
4D Molecular Therapeutics Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |